201 related articles for article (PubMed ID: 29261651)
1. Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection.
Goedhals D; Paweska JT; Burt FJ
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006149. PubMed ID: 29261651
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
[TBL] [Abstract][Full Text] [Related]
3. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
4. Fine epitope mapping of the central immunodominant region of nucleoprotein from Crimean-Congo hemorrhagic fever virus (CCHFV).
Liu D; Li Y; Zhao J; Deng F; Duan X; Kou C; Wu T; Li Y; Wang Y; Ma J; Yang J; Hu Z; Zhang F; Zhang Y; Sun S
PLoS One; 2014; 9(11):e108419. PubMed ID: 25365026
[TBL] [Abstract][Full Text] [Related]
5. Identification of T cell responses to the nonstructural glycoproteins in survivors of Crimean-Congo hemorrhagic fever in South Africa.
Maotoana MG; Burt FJ; Goedhals D
J Med Virol; 2023 Oct; 95(10):e29154. PubMed ID: 37812041
[TBL] [Abstract][Full Text] [Related]
6. Sensitive and specific detection of Crimean-Congo Hemorrhagic Fever Virus (CCHFV)-Specific IgM and IgG antibodies in human sera using recombinant CCHFV nucleoprotein as antigen in μ-capture and IgG immune complex (IC) ELISA tests.
Emmerich P; Mika A; von Possel R; Rackow A; Liu Y; Schmitz H; Günther S; Sherifi K; Halili B; Jakupi X; Berisha L; Ahmeti S; Deschermeier C
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006366. PubMed ID: 29579040
[TBL] [Abstract][Full Text] [Related]
7. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens.
Nosrati M; Mohabatkar H; Behbahani M
Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
9. Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach.
Fritzen A; Risinger C; Korukluoglu G; Christova I; Corli Hitzeroth A; Viljoen N; Burt FJ; Mirazimi A; Blixt O
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006598. PubMed ID: 29985929
[TBL] [Abstract][Full Text] [Related]
10. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
Front Immunol; 2021; 12():669812. PubMed ID: 34220816
[TBL] [Abstract][Full Text] [Related]
11. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
[TBL] [Abstract][Full Text] [Related]
12. CD8
Rao D; Meade-White K; Leventhal S; Mihalakakos E; Carmody A; Feldmann H; Hawman DW
EBioMedicine; 2023 Nov; 97():104839. PubMed ID: 37866114
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping epitope on glycoprotein-Gn from Crimean-Congo hemorrhagic fever virus.
Shalitanati A; Yu H; Liu D; Xu WX; Yue X; Guo R; Li Y; Deng F; Yang J; Zhang Y; Sun S
Comp Immunol Microbiol Infect Dis; 2018 Aug; 59():24-31. PubMed ID: 30290884
[TBL] [Abstract][Full Text] [Related]
14. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.
Fels JM; Maurer DP; Herbert AS; Wirchnianski AS; Vergnolle O; Cross RW; Abelson DM; Moyer CL; Mishra AK; Aguilan JT; Kuehne AI; Pauli NT; Bakken RR; Nyakatura EK; Hellert J; Quevedo G; Lobel L; Balinandi S; Lutwama JJ; Zeitlin L; Geisbert TW; Rey FA; Sidoli S; McLellan JS; Lai JR; Bornholdt ZA; Dye JM; Walker LM; Chandran K
Cell; 2021 Jun; 184(13):3486-3501.e21. PubMed ID: 34077751
[TBL] [Abstract][Full Text] [Related]
15. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.
Mishra AK; Moyer CL; Abelson DM; Deer DJ; El Omari K; Duman R; Lobel L; Lutwama JJ; Dye JM; Wagner A; Chandran K; Cross RW; Geisbert TW; Zeitlin L; Bornholdt ZA; McLellan JS
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996434
[TBL] [Abstract][Full Text] [Related]
16. Identification of human linear B-cell epitope sites on the envelope glycoproteins of Crimean-Congo haemorrhagic fever virus.
Goedhals D; Paweska JT; Burt FJ
Epidemiol Infect; 2015 May; 143(7):1451-6. PubMed ID: 25185583
[TBL] [Abstract][Full Text] [Related]
17. Human defined antigenic region on the nucleoprotein of Crimean-Congo hemorrhagic fever virus identified using truncated proteins and a bioinformatics approach.
Burt FJ; Samudzi RR; Randall C; Pieters D; Vermeulen J; Knox CM
J Virol Methods; 2013 Nov; 193(2):706-12. PubMed ID: 23933073
[TBL] [Abstract][Full Text] [Related]
18. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.
Kempster S; Hassall M; Graham V; Kennedy E; Findlay-Wilson S; Salguero FJ; Bagci B; Elaldi N; Oz M; Tasseten T; Charlton FW; Barr JN; Fontana J; Duru C; Ezeajughi E; Matejtschuk P; Arnold U; Adedeji Y; Mirazimi A; Hewson R; Dowall S; Almond N
Virus Res; 2024 Aug; 346():199409. PubMed ID: 38815869
[TBL] [Abstract][Full Text] [Related]
19. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
[TBL] [Abstract][Full Text] [Related]
20. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
